Pelthos Therapeutics Inc. financial data

Symbol
PTHS on NYSE
Location
Durham, NC
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128% % 128%
Debt-to-equity 189% %
Return On Equity -210% % -136%
Return On Assets -73% % 84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,061,681 shares -49%
Common Stock, Shares, Outstanding 3,090,729 shares -47%
Entity Public Float $6,800,000 USD
Common Stock, Value, Issued $67 USD -89%
Weighted Average Number of Shares Outstanding, Basic 3,061,488 shares 429%
Weighted Average Number of Shares Outstanding, Diluted 3,061,488 shares 429%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $7,406,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $294,000 USD
Research and Development Expense $1,138,987 USD -64%
General and Administrative Expense $4,312,743 USD 16%
Operating Income (Loss) $22,250,781 USD -131%
Nonoperating Income (Expense) $1,794,360 USD -306%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,703,000 USD -885%
Income Tax Expense (Benefit) $465,000 USD
Net Income (Loss) Attributable to Parent $23,581,338 USD -134%
Earnings Per Share, Basic -5 USD/shares 35%
Earnings Per Share, Diluted -5 USD/shares -81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $14,203,000 USD
Inventory, Net $24,096,000 USD
Other Assets, Current $574,000 USD
Assets, Current $49,761,000 USD 2225%
Property, Plant and Equipment, Net $10,174,000 USD
Operating Lease, Right-of-Use Asset $3,352,000 USD
Intangible Assets, Net (Excluding Goodwill) $32,521,000 USD
Goodwill $30,625,000 USD
Assets $126,433,000 USD 5808%
Accounts Payable, Current $5,666,000 USD
Accrued Liabilities, Current $11,890,000 USD 3760%
Liabilities, Current $24,768,000 USD 594%
Deferred Income Tax Liabilities, Net $12,866,000 USD
Other Liabilities, Noncurrent $26,175,000 USD
Liabilities $68,180,000 USD 1811%
Retained Earnings (Accumulated Deficit) $43,130,000 USD -121%
Stockholders' Equity Attributable to Parent $58,253,000 USD
Liabilities and Equity $126,433,000 USD 5808%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $632,126 USD 68%
Net Cash Provided by (Used in) Financing Activities $250,000 USD -96%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 3,090,729 shares -47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14,253,000 USD 1036%
Interest Paid, Excluding Capitalized Interest, Operating Activities $11,250 USD
Deferred Tax Assets, Valuation Allowance $5,591,819 USD 54%
Deferred Tax Assets, Gross $5,591,819 USD 54%
Operating Lease, Liability $2,849,000 USD
Property, Plant and Equipment, Gross $10,563,000 USD
Operating Lease, Liability, Current $631,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,048,000 USD
Additional Paid in Capital $101,383,000 USD 460%
Operating Leases, Future Minimum Payments, Due in Two Years $665,000 USD
Amortization of Intangible Assets $679,000 USD
Operating Leases, Future Minimum Payments, Due in Three Years $685,000 USD
Operating Leases, Future Minimum Payments Due $164,000 USD
Interest Expense $1,346,000 USD 3351%